Summary
UnitedHealth Group Inc. (UNH) filed an 8-K on November 19, 2012, reporting on significant developments regarding its acquisition of Amil Participações S.A. (Amil), a Brazilian healthcare company. The company had already acquired approximately 60% of Amil's shares in October 2012 and announced its intention to launch a tender offer for an additional 30% of Amil's outstanding common shares from public shareholders in early 2013. This strategic move signals UnitedHealth Group's expansion into the Brazilian market. The filing also discloses that UnitedHealth Group has received exemptive relief from Rule 14e-5 of the Securities Exchange Act of 1934. This exemption allows the company and its affiliates to continue purchasing Amil shares outside of the formal tender offer. These purchases may occur in the open market or through private transactions, subject to specific conditions and disclosure requirements in both Brazil and the United States. Investors should monitor future disclosures regarding these purchases as they may impact the tender offer's success and the final ownership structure.
Key Highlights
- 1UnitedHealth Group (UNH) acquired approximately 60% of Amil Participações S.A. (Amil) shares in October 2012.
- 2UNH plans to launch a tender offer for an additional 30% of Amil's outstanding common shares in Q1 2013.
- 3This acquisition represents a significant expansion of UNH's international presence, specifically in the Brazilian healthcare market.
- 4UNH has obtained exemptive relief from Rule 14e-5 under the Securities Exchange Act of 1934.
- 5The exemptive relief permits UNH and its affiliates to purchase Amil shares outside of the tender offer, subject to certain conditions.
- 6These purchases may occur in the open market or via private transactions.
- 7Information on these outside purchases will be disclosed as required by Brazilian and U.S. laws.